Surgical and minimally invasive treatments for Peyronie's disease

Current Opinion in Urology

Volumn 19, Issue 6, 2009, Pages 589-594

  Kumar, Rajeev ^a   Nehra, Ajay ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b MAYO CLINIC   (United States)

Author keywords

Allografts; Injection therapy; Peyronie's disease; Phalloplasty

Indexed keywords

4 AMINOBENZOATE POTASSIUM; 4 AMINOBENZOIC ACID; ALPHA TOCOPHEROL; ALPHA2B INTERFERON; COLCHICINE; COLLAGENASE; INTERFERON; MAGNESIUM SULFATE; PHOSPHODIESTERASE V INHIBITOR; POLITEF; PROPIONYLCARNITINE; TAMOXIFEN; TRIFLUOPERAZINE; VERAPAMIL;

ALLOGRAFT; AUTOGRAFT; CLINICAL TRIAL; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; EXTRACORPOREAL SHOCK WAVE THERAPY; HUMAN; LIVER INJURY; MALE; MINIMALLY INVASIVE PROCEDURE; MINIMALLY INVASIVE SURGERY; NONHUMAN; PEYRONIE DISEASE; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TRACTION THERAPY; XENOGRAFT;

ANIMALS; HUMANS; MALE; PENILE INDURATION;

EID: 70350052707     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283314a87     Document Type: Review

References (39)

1. Peyronie DL. Sur quelques obstacles qui s'opposent a l'ejaculation naturelle de la semence. Mem Acad R Chir 1743; 1:425.
2. Lindsay MB, Schain DM, Grambasch P. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991; 146:1007-1009.
3. Devine CJ. International Conference on Peyronie's disease advances in basic and clinical research. March 17-19, 1993. Introduction. JUrol 1997; 157:272-275.
4. Smith BH. Subclinical Peyronie's disease. Am J Clin Pathol 1969; 52:385-390.
5. Carrier S, Lue TF. For Peyronie's disease, act conservatively. Contemp Urol 1994; 6:54-65.
6. Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. J Urol 2007; 178 (4 Pt 1):1398-1403.
7. Brant WO. Editorial comment. J Urol 2007; 178 (4 Pt 1):1403.
8. Roy J, Carrier S. Acute hepatitis associated with treatment of Peyronie's disease with potassium para-aminobenzoate (Potaba). J Sex Med 2008; 5:2967-2969.
9. Russell S, Steers W, McVary KT. Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease. Eur Urol 2007; 51:640-647.
10. Bennett NE, Guhring P, Mulhall JP. Intralesional verapamil prevents the progression of Peyronie's disease. Urology 2007; 69:1181-1184.
11. Shirazi M, Haghpanah AR, Badiee M, et al. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study. Int Urol Nephrol 2009; 41:467-471.
12. Levine LA, Estrada CR, Shou W, Cole A. Tunica albuginea tissue analysis after electromotive drug administration. J Urol 2003; 169:1775-1778.
13. Greenfield JM, Shah SJ, Levine LA. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol 2007; 177:972-975.
14. Fitch WP 3rd, Easterling WJ, Talbert RL, et al. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease: a placebo-controlled pilot study. J Sex Med 2007; 4:477-484.
15. Hellstrom WJ, Kendirci M, Matern R, et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease. J Urol 2006; 176:394-398.
16. Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, nonplacebo-controlled study. J Sex Med 2008; 5:180-187.
17. Srirangam SJ, Manikandan R, Hussain J, et al. Long-term results of extracorporeal shockwave therapy for Peyronie's disease. J Endourol 2006; 20: 880-884.
18. Palmieri A, Imbimbo C, Longo N, et al. A first prospective, randomized, doubleblind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol 2009; 56:363-370.
19. Trott KR, Kamprad F. Radiobiological mechanisms of anti-inflammatory radiotherapy. Radiother Oncol 1999; 51:197-203.
20. Incrocci L, Hop WC, Seegenschmiedt HM. Radiotherapy for Peyronie's disease: a European survey. Acta Oncol 2008; 47:1110-1112.
21. Pryor JP, Fitzpatrick JM. A new approach to the correction of the penile deformity in Peyronie's disease. J Urol 1979; 122:622-623.
22. Taylor FL, Levine LA. Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up. J Sex Med 2008; 5:2221-2228.
23. Cavallini G, Caracciolo S. Pilot study to determine improvements in subjective penile morphology and personal relationships following a Nesbit plication procedure for men with congenital penile curvature. Asian J Androl 2008; 10:512-519.
24. Fazili T, Kouriefs C, Anjum F, et al. Ten years outcome analysis of corporeal plication for Peyronie's disease. Int Urol Nephrol 2007; 39:111-114.
25. Essed E, Schroeder FH. New surgical treatment for Peyronie's disease. Urology 1985; 25:582-587.
26. Kadioglu A, Sanli O, Akman T, et al. Surgical treatment of Peyronie's disease: a single center experience with 145 patients. Eur Urol 2008; 53:432-439.
27. Bruner B, Kumar R, Kumar S, et al. Long-term results of a modified Essed- Schroeder technique: surgical correction of Peyronie's disease associated with severe dorsal curvature. J Urol 2009; 181 (Suppl):203.
28. Paez A, Mejias J, Vallejo J, et al. Long-term patient satisfaction after surgical correction of penile curvature via tunical plication. Int Braz J Urol 2007; 33:502-507.
29. KendirciM, Hellstrom WJG. Critical analysis of surgery for Peyronie's disease. Curr Opin Urol 2004; 14:381-388.
30. Hsu GL, Chen HS, Hsieh CH, et al. Long-term results of autologous venous grafts for penile morphological reconstruction. J Androl 2007; 28:186-193.
31. Badylak SF. Small intestinal submucosa (SIS): a biomaterial conducive to smart tissue remodeling. In: Bell E, editor. Tissue engineering: current perspectives. Cambridge, Massachusetts: Burkhauser Publishers; 1993. pp. 179-189.
32. Knoll LD. Use of small intestinal submucosa graft for the surgical management of Peyronie's disease. J Urol 2007; 178:2474-2478.
33. Breyer BN, Brant WO, Garcia MM, et al. Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol 2007; 177:589-591.
34. Kovac JR, Brock GB. Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie's disease. J Sex Med 2007; 4:1500-1508.
35. Rolle L, Tamagnone A, Bollito E, et al. Could plaque excision surgery with sis graft induce a new fibrotic reaction in la Peyronie's disease patients? Arch Ital Urol Androl 2007; 79:167-169.
36. Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study. J Sex Med 2008; 5:1468-1473.
37. Piao S, Ryu JK, Shin HY, et al. Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease. Int J Androl 2008; 31:346-353.
38. Lucattelli M, Lunghi B, Fineschi S, et al. A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. Int J Biochem Cell Biol 2008; 40:2638-2648.
39. Taylor FL, Levine LA. Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up. Author response. J Sex Med 2008; 5:2230.